Canada markets close in 10 minutes

Hansa Biopharma AB (publ) (24H.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
2.4800-0.0960 (-3.73%)
As of 09:09AM CEST. Market open.
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
139,158
134,094
154,525
33,878
6,098
Cost of Revenue
37,565
63,143
38,477
15,425
997
Gross Profit
101,593
70,951
116,048
18,453
5,101
Operating Expenses
Research Development
322,210
411,332
346,244
230,764
227,191
Selling General and Administrative
357,336
450,492
337,861
327,269
202,987
Total Operating Expenses
699,295
862,110
692,168
558,033
430,178
Operating Income or Loss
-597,702
-791,159
-576,120
-539,580
-425,077
Interest Expense
144,492
105,520
43,666
694
257
Income Before Tax
-625,030
-830,812
-609,979
-548,130
-420,893
Income Tax Expense
820
908
1,155
152
-40
Income from Continuing Operations
-625,850
-831,720
-611,134
-548,282
-420,853
Net Income
-625,850
-831,720
-611,134
-548,282
-420,853
Net Income available to common shareholders
-625,850
-831,720
-611,134
-548,282
-420,853
Basic EPS
-16.70
-15.83
-13.60
-12.33
-9.98
Diluted EPS
-16.70
-15.83
-13.60
-12.33
-9.98
Basic Average Shares
50,868
52,540
44,924
44,473
42,177
Diluted Average Shares
50,868
52,540
44,924
44,473
42,177